This qualitative study explored how pregnancy and parenting affect decisions about medications for opioid use disorder. Researchers conducted semi-structured interviews with 26 women who had previously used medication treatment, on average 10.1 months after delivery, and analyzed their accounts of treatment barriers and supports.
Four themes emerged: limited autonomy in medication decisions; reluctance to use treatment because of concerns about newborn withdrawal; fear of child protective services involvement or custody loss following exposure reporting; and treatment settings, especially inflexible methadone-clinic requirements, that did not adequately accommodate postpartum needs. The authors describe a conflict between encouragement to remain in evidence-based treatment and fear of negative consequences after delivery. They recommend shared decision-making, education about medication safety, reconsideration of reporting practices, and more equitable, gender-responsive treatment.
Original summary for clinical review. Read the published study.
